On August 23, 2020, the Board of Directors of Helius Medical Technologies, Inc. appointed Dane C. Andreeff as the company’s Interim President effective immediately. Mr. Andreeff will continue to serve as a director of the Company. Mr. Andreeff succeeds Phillippe Deschamps who stepped down from his roles as President and director of the Company effective August 23, 2020 upon mutual agreement with the Board. In connection with the appointment of Mr. Andreeff as the company’s Interim President, the Board removed Mr. Andreeff from the Compensation Committee and the Nominating and Corporate Governance Committee, appointed Edward M. Straw to the Compensation Committee and named Vice Admiral (Retired) Straw as chair of such committee. Effective as of August 23, 2020, the Board of the company appointed Board member Blane Walter as the Chairman of the Board. On August 25, 2020, the company announced that the Board and Phillippe Deschamps had mutually agreed that Mr. Deschamps would step down from his positions as President of the Company effective August 23, 2020 (the “Separation Date”). Effective as of the Separation Date, Mr. Deschamps also resigned from the Board, and the Board reduced its size from six directors to five directors.